Citius Oncology (CTOR) Work In Process (2024 - 2026)

Citius Oncology (CTOR) has 3 years of Work In Process data on file, last reported at $7.0 million in Q1 2026.

• On a quarterly basis, Work In Process changed N/A year-over-year to $7.0 million in Q1 2026; TTM through Mar 2026 was $7.0 million, a N/A change from a year earlier, with the FY2025 full-year figure at $11.7 million, up 448.71% from the prior year.
• Work In Process for Q1 2026 stood at $7.0 million, roughly flat from $7.0 million in the prior quarter.
• Over the last five years, Work In Process for CTOR reached as high as $11.7 million in Q3 2025 and fell as low as $2.1 million in Q3 2024.
• Historically, Work In Process has averaged $6.9 million across 3 years, with a median of $7.0 million in 2025.
• On a YoY basis, Work In Process climbed as much as 448.71% in 2025 and fell as far as 448.71% in 2025.
• Year by year, Work In Process stood at $2.1 million in 2024, then surged by 225.79% to $7.0 million in 2025, then changed by 0.0% to $7.0 million in 2026.
• Per Business Quant data, the three most recent Work In Process figures were $7.0 million in Q1 2026, $7.0 million in Q4 2025, and $11.7 million in Q3 2025.